The Green Organic Dutchman achieves major milestone as it begins cannabis sales to medical patients

The Green Organic Dutchman Holdings Ltd (TSE:TGOD) (OTCMKTS:TGODF) announced Monday that it has begun selling cannabis to a national network of medical patients, marking a major milestone in the company’s production strategy.

The launch is a limited rollout of the company’s certified-organic cannabis to a select group of patients across Canada known as The Growers’ Circle, allowing the company to perfect its distribution ahead of a planned production ramp-up later this year.

The Toronto-based company is now shipping its Unite Organic strain to more than 200 medical patients within Canada and plans to expand the list of Growers’ Circle members as more supply comes online.

READ: The Green Organic Dutchman ends 2018 with strong balance sheet, liquidity

“The launch of the Growers’ Circle is another significant moment in TGOD’s commercial story,” said Brian Athaide, the company’s CEO. “Our certified-organic cannabis is a premium experience for patients. We are proud of our product and excited to be sharing it with Growers’ Circle members.”

The company’s cannabis is grown in living soil without synthetic fertilizers, pesticides or herbicides, earning certified organic status by global certification bodies ECOCERT and Pro-cert.

Shares of The Green Organic Dutchman were trading at $4.77 in Toronto and US$3.57 in the US prior to Monday’s market open.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Story by ProactiveInvestors